Cargando…
CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY
OBJECTIVE: Perioperative deep prosthetic joint infection (PJI) is a serious postoperative complication of total hip arthroplasty (THA). We aimed to compare the efficacy of cefazolin administered within 24 and 48 h of primary THA for PJI prophylaxis. METHODS: In this retrospective study, 720 patients...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ATHA EDITORA
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721432/ https://www.ncbi.nlm.nih.gov/pubmed/36506857 http://dx.doi.org/10.1590/1413-785220223002e248417 |
_version_ | 1784843773788815360 |
---|---|
author | Kobayashi, Shunsuke Yasu, Takeo Tagawa, Seiji Ogura, Takashi Kitaoka, Akira Matsubara, Masaaki |
author_facet | Kobayashi, Shunsuke Yasu, Takeo Tagawa, Seiji Ogura, Takashi Kitaoka, Akira Matsubara, Masaaki |
author_sort | Kobayashi, Shunsuke |
collection | PubMed |
description | OBJECTIVE: Perioperative deep prosthetic joint infection (PJI) is a serious postoperative complication of total hip arthroplasty (THA). We aimed to compare the efficacy of cefazolin administered within 24 and 48 h of primary THA for PJI prophylaxis. METHODS: In this retrospective study, 720 patients were divided into two groups depending on whether cefazolin was administered as a single injection of 2 g twice daily within 24 (24-h group) or 48 h of surgery and the following day (48-h group). Sex, age at surgery, body mass index, co-existing diseases, blood test data, and PJI risk factors were evaluated. RESULTS: The 24- and 48-h groups included 364 and 356 patients, respectively. Diabetes mellitus was the most common risk factor for PJI in both groups. The corresponding incidence of perioperative deep PJI following primary THA was 0.55% and 0.28% in the 24- and 48-h groups, respectively. There was no significant difference in patient background characteristics between the groups. CONCLUSIONS: Cefazolin administration within 24 h of primary THA may be appropriate for perioperative deep PJI. Level of Evidence II; Retrospective study . |
format | Online Article Text |
id | pubmed-9721432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | ATHA EDITORA |
record_format | MEDLINE/PubMed |
spelling | pubmed-97214322022-12-09 CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY Kobayashi, Shunsuke Yasu, Takeo Tagawa, Seiji Ogura, Takashi Kitaoka, Akira Matsubara, Masaaki Acta Ortop Bras Original Article OBJECTIVE: Perioperative deep prosthetic joint infection (PJI) is a serious postoperative complication of total hip arthroplasty (THA). We aimed to compare the efficacy of cefazolin administered within 24 and 48 h of primary THA for PJI prophylaxis. METHODS: In this retrospective study, 720 patients were divided into two groups depending on whether cefazolin was administered as a single injection of 2 g twice daily within 24 (24-h group) or 48 h of surgery and the following day (48-h group). Sex, age at surgery, body mass index, co-existing diseases, blood test data, and PJI risk factors were evaluated. RESULTS: The 24- and 48-h groups included 364 and 356 patients, respectively. Diabetes mellitus was the most common risk factor for PJI in both groups. The corresponding incidence of perioperative deep PJI following primary THA was 0.55% and 0.28% in the 24- and 48-h groups, respectively. There was no significant difference in patient background characteristics between the groups. CONCLUSIONS: Cefazolin administration within 24 h of primary THA may be appropriate for perioperative deep PJI. Level of Evidence II; Retrospective study . ATHA EDITORA 2022-12-02 /pmc/articles/PMC9721432/ /pubmed/36506857 http://dx.doi.org/10.1590/1413-785220223002e248417 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kobayashi, Shunsuke Yasu, Takeo Tagawa, Seiji Ogura, Takashi Kitaoka, Akira Matsubara, Masaaki CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY |
title | CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY |
title_full | CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY |
title_fullStr | CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY |
title_full_unstemmed | CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY |
title_short | CEFAZOLIN PROPHYLACTIC EFFICACY ON PROSTHETIC JOINT INFECTION AFTER PRIMARY HIP ARTHROPLASTY |
title_sort | cefazolin prophylactic efficacy on prosthetic joint infection after primary hip arthroplasty |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721432/ https://www.ncbi.nlm.nih.gov/pubmed/36506857 http://dx.doi.org/10.1590/1413-785220223002e248417 |
work_keys_str_mv | AT kobayashishunsuke cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty AT yasutakeo cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty AT tagawaseiji cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty AT oguratakashi cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty AT kitaokaakira cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty AT matsubaramasaaki cefazolinprophylacticefficacyonprostheticjointinfectionafterprimaryhiparthroplasty |